title: Synergistic induction of bone formation by hOP-1, hTGF-beta3 and inhibition by zoledronate in macroporous coral-derived hydroxyapatites.
abstract: Thirty coral-derived calcium carbonate-based macroporous constructs with limited hydrothermal conversion to hydroxyapatite (7% HA/CC) were implanted in the rectus abdominis of three adult non-human primate Papio ursinus to investigate the intrinsic induction of bone formation. Macroporous constructs with 125 microg human recombinant osteogenic protein-1 (hOP-1) or 125 microg human recombinant transforming growth factor-beta(3) (hTGF-beta(3)) were also implanted. The potential synergistic interaction between morphogens was tested by implanting binary applications of hOP-1 and hTGF-beta(3) 5:1 by weight, respectively. To evaluate the role of osteoclastic activity on the implanted macroporous surfaces, coral-derived constructs were pre-loaded with 0.24 mg of bisphosphonate zoledronate (Zometa). To correlate the morphology of tissue induction with osteogenic gene expression and activation, harvested specimens on day 90 were analyzed for changes in OP-1 and TGF-beta(3) mRNA synthesis by quantitative real-time polymerase chain reaction (qRT-PCR). The induction of bone formation in 7% HA/CC solo correlated with OP-1 expression. Massive bone induction formed by binary applications of the recombinant morphogens. Single applications of hOP-1 and hTGF-beta(3) also resulted in substantial bone formation, not comparable however to synergistic binary applications. Zoledronate-treated macroporous constructs showed limited bone formation and in two specimens bone formation was altogether absent; qRT-PCR showed a prominent reduction of OP-1 gene expression whilst TGF-beta(3) expression was far greater than OP-1. The lack of bone formation by zoledronate-treated specimens indicates that osteoclastic activity on the implanted coral-derived constructs is critical for the spontaneous induction of bone formation. Indirectly, zoledronate-treated samples showing lack of OP-1 gene expression and absent or very limited bone formation by induction confirm that the spontaneous induction of bone formation by coral-derived macroporous constructs is initiated by secreted BMPs/OPs, in context the OP-1 isoform.
authors.affiliation: Bone Research Unit, Medical Research Council/University of the Witwatersrand, Johannesburg, South Africa. ugo.ripamonti@wits.ac.za
authors.forename: Ugo
authors.initials: U
authors.lastname: Ripamonti
authors.forename: Roland M
authors.initials: RM
authors.lastname: Klar
authors.forename: Louise F
authors.initials: LF
authors.lastname: Renton
authors.forename: Carlo
authors.initials: C
authors.lastname: Ferretti
mesh_terms: D000818:Animals; D037421:Anthozoa / Q000737:chemistry; D050071:Bone Density Conservation Agents / Q000494:pharmacology*; D055419:Bone Morphogenetic Protein 7 / Q000378:metabolism*; D002119:Calcium Carbonate / Q000737:chemistry; D004164:Diphosphonates / Q000494:pharmacology*; D017886:Durapatite / Q000737:chemistry*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D020007:Implants, Experimental; D010012:Osteogenesis / Q000187:drug effects*; D048549:Papio ursinus / Q000502:physiology*; D016062:Porosity; D011994:Recombinant Proteins / Q000378:metabolism; D017568:Rectus Abdominis / Q000502:physiology; D053782:Transforming Growth Factor beta3 / Q000378:metabolism*; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D055419:Bone Morphogenetic Protein 7; D004164:Diphosphonates; D007093:Imidazoles; D011994:Recombinant Proteins; D053782:Transforming Growth Factor beta3; D000077211:Zoledronic Acid; D017886:Durapatite; D002119:Calcium Carbonate